Hello, Guest!
  • Friday, November 15, 2024

AstraZeneca Receives $205M Army COVID-19 Antibody Drug Order

The U.S. Army has reserved at least 100,000 doses of AstraZeneca’s AZD7442, a long-acting antibody product designed to prevent COVID-19 infection or treat the coronavirus disease, through a $204.9 million contract modification.

The service branch obligated the full amount using its fiscal 2021 research, development, test and evaluation funds, the Department of Defense said Tuesday.

Contract work will take place in Wilmington, Delaware, through Dec. 31.

AstraZeneca licensed the AZD7442 combination therapy of two long-acting antibodies from the Vanderbilt University Medical Center in Nashville, Tennessee, last year and engineered the drug using the company’s proprietary half-life extension technology.

A Phase III clinical trial is underway to evaluate the efficacy and safety of the LAAB combo product as a treatment for non-hospitalized COVID-19 patients.

Video of the Day

Related Articles

General Dynamics Land Systems Secures $297M Army M10 Booker System Technical Support Contract Contract Awards

General Dynamics Land Systems Secures $297M Army M10 Booker System Technical Support Contract

A General Dynamics (NYSE: GD) subsidiary has received a potential five-year, $296.8 million contract from the U.S. Army to provide system technical support for the military branch’s M10 Booker combat vehicle. Army Contracting Command will obligate funds and determine work locations upon award of each task order and expects contract work to run through April

Leidos Wins $631M Army Contract for Aerial ISR Sensor Life Cycle Support Contract Awards

Leidos Wins $631M Army Contract for Aerial ISR Sensor Life Cycle Support

Leidos (NYSE: LDOS) has secured a potential 10-year, $631.2 million contract to help the U.S. Army develop, acquire and provide life cycle support to tactical aerial intelligence, surveillance and reconnaissance sensors and integrated systems. Army Contracting Command will determine work locations and funding for each order under the Development, Integration, Acquisition, Bridging to Logistics &

General Dynamics, Northrop Win Spots on $3B Army Medium Caliber Cartridge Production Contract Contract Awards

General Dynamics, Northrop Win Spots on $3B Army Medium Caliber Cartridge Production Contract

A General Dynamics (NYSE: GD) business and Northrop Grumman (NYSE: NOC) have won positions on a potential five-year, $3.05 billion contract to provide medium caliber training cartridges for the U.S. Army. Army Contracting Command received two bids for the cost-plus-fixed-fee, fixed-price contract through an online solicitation and will obligate funds and determine work locations upon